Oncology Drugs Market Size, Share & Industry Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 11.3% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Drug Class

• Cytotoxic Drugs
• Alkylating Agents
• Antimetabolites
• Others
• Targeted Drugs
• Monoclonal Antibodies
• Others
• Hormonal Drugs
• Others

By Therapy

• Chemotherapy
• Targeted Therapy
• Immunotherapy

By Indication

• Lung Cancer
• Stomach Cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Others

By Dosage Form

• Solid
• Tablets
• Capsules
• Liquid
• Injectable
• Prefilled Syringes
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America (By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region)
  • U.S. (By Drug Class)
  • Canada (By Drug Class)
• Europe (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region)
  • U.K. (By Drug Class)
  • Germany (By Drug Class)
  • France (By Drug Class)
  • Italy (By Drug Class)
  • Spain (By Drug Class)
  • Scandinavia (By Drug Class)
  • Rest of Europe (By Drug Class)
• Asia Pacific (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region)
  • Japan (By Drug Class)
  • China (By Drug Class)
  • India (By Drug Class)
  • Australia (By Drug Class)
  • Southeast Asia (By Drug Class)
  • Rest of Asia Pacific (By Drug Class)
• Latin America (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region)
  • Brazil (By Drug Class)
  • Mexico (By Drug Class)
  • Rest of Latin America (By Drug Class)
• Middle East & Africa (By Drug Class, By Drug Class, By Therapy, By Indication, By Dosage Form, By Distribution Channel, By Country/Sub-Region)
  • South Africa (By Drug Class)
  • GCC (By Drug Class)
  • Rest of Middle East & Africa (By Drug Class)